Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.

Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Canadian researchers find that taking semaglutide increases the chances of developing neovascular age-related macular ...

New research found a link between GLP-1 use in people with diabetes and an elevated chance of wet AMD, which can cause blindness. Nick Blackmer is a librarian, fact-checker, and researcher with ...

Regeneron acquired a promising weight management asset that could become lucrative. Shares of Regeneron (NASDAQ: REGN) have declined this year due to issues with one of its former growth drivers, ...